The FDA has granted Pops! Diabetes Care clearance to market its Pops! one Blood Glucose Monitoring System, which enables review of blood glucose trends by users and data sharing with health care providers and family members. The system, which uses a coaching app to interact with users, is expected to be released early next year.
FDA clears Pops! Diabetes' blood glucose monitoring system
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.